Are Olympic athletes free from cardiovascular diseases? Systematic investigation in 2352 participants from Athens 2004 to Sochi 2014
暂无分享,去创建一个
Viviana Maestrini | Antonio Spataro | Stefano Caselli | Paolo Emilio Adami | S. Caselli | A. Pelliccia | A. Spataro | V. Maestrini | Antonio Pelliccia | F. D. Di Paolo | C. Pisicchio | Cataldo Pisicchio | Filippo Quattrini | Maria Rosaria Squeo | Luisa Verdile | Fernando Di Paolo | Roberto Ciardo | P. Adami | F. Quattrini | M. Squeo | L. Verdile | R. Ciardo
[1] F. Rutten,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.
[2] G. Matheson,et al. The International Olympic Committee (IOC) Consensus Statement on periodic health evaluation of elite athletes March 2009 , 2009, British Journal of Sports Medicine.
[3] S. Caselli,et al. Three-dimensional echocardiographic characterization of left ventricular remodeling in Olympic athletes. , 2011, The American journal of cardiology.
[4] M. Link,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.
[5] Michael Böhm,et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.
[6] B. Maron,et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. , 2002, Journal of the American College of Cardiology.
[7] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[8] J. Stockman. Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program , 2008 .
[9] Barry J Maron,et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. , 2006, European heart journal.
[10] B. Maron. Sudden death in young athletes. , 1980, The New England journal of medicine.
[11] J. Dvořák,et al. The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes: March 2009. , 2009, Journal of athletic training.
[12] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[13] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.
[14] D. Corrado,et al. Italian cardiological guidelines for sports eligibility in athletes with heart disease: part 1. , 2013, Journal of cardiovascular medicine.
[15] Nancy M Albert,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.
[16] B. Maron,et al. Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2009, Circulation.
[17] B. Maron,et al. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. , 1995, The American journal of cardiology.
[18] Thoralf M Sundt,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.
[19] R A Levine,et al. Prevalence and clinical outcome of mitral-valve prolapse. , 1999, The New England journal of medicine.
[20] N. Al-Attar. Faculty Opinions recommendation of 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014 .
[21] Andrea Mazzanti,et al. [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.
[22] Hein Heidbuchel,et al. Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’ , 2013, British Journal of Sports Medicine.
[23] Arturo Evangelista,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[24] M. Link,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Journal of the American College of Cardiology.
[25] A. Ryan,et al. The Olympic games. , 1956, Journal of the American Medical Association.
[26] Barry J Maron,et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. , 2009, European heart journal.
[27] B. Maron,et al. Outcomes in athletes with marked ECG repolarization abnormalities. , 2008, The New England journal of medicine.
[28] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[29] B. Maron,et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. , 2000, Circulation.
[30] Jonathan A Drezner,et al. Incidence of sudden cardiac death in athletes: a state-of-the-art review , 2014, British Journal of Sports Medicine.
[31] M. Link,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Journal of the American College of Cardiology.
[32] Thoralf M Sundt,et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[33] D. Adedinsewo,et al. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. , 2015, The American journal of cardiology.